Bolton, MA, United States of America

Zhengyu Long

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Zhengyu Long in Pharmaceutical Science

Introduction

Zhengyu Long is a notable inventor based in Bolton, MA (US), recognized for his contributions to pharmaceutical science. He holds a total of four patents, showcasing his innovative approach to addressing various health issues through chemical compounds.

Latest Patents

Among his latest patents is a significant invention related to Cyclosporin derivatives and their uses. This invention pertains to a compound of a specific formula, which can be utilized in pharmaceutical compositions. The applications of this compound include methods for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss. This innovative work highlights the potential of Cyclosporin derivatives in advancing medical treatments.

Career Highlights

Zhengyu Long is currently associated with S&T Global Inc., where he continues to develop and refine his inventions. His work in the pharmaceutical field has positioned him as a key figure in the development of new therapeutic solutions.

Collaborations

Zhengyu collaborates with talented individuals such as Zhuang Su and Zhennian Huang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhengyu Long's contributions to pharmaceutical science through his patents and collaborations reflect his commitment to improving health outcomes. His innovative work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…